Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,275,352 papers from all fields of science
Search
Sign In
Create Free Account
Epithelial ovarian cancer
Known as:
carcinoma, ovarian epithelial
, Ovarian epithelial cancer
, epithelial ovarian carcinoma
Expand
A malignant neoplasm originating from the surface ovarian epithelium. It accounts for the greatest number of deaths from malignancies of the female…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
ADAM11 protein, human
AKT2 protein, human
AKT2 wt Allele
BRCA1 Associated RING Domain 1 Protein
Expand
Narrower (1)
Malignant Brenner Tumor
Broader (4)
Neoplasms
Neoplasms, Glandular and Epithelial
Ovarian Carcinoma
ovarian neoplasm
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
R. Burger
,
M. Brady
,
+10 authors
S. Liang
New England Journal of Medicine
2011
Corpus ID: 76416892
BACKGROUND Vascular endothelial growth factor is a key promoter of angiogenesis and disease progression in epithelial ovarian…
Expand
Highly Cited
2011
Highly Cited
2011
A phase 3 trial of bevacizumab in ovarian cancer.
T. Perren
,
A. Swart
,
+23 authors
A. Oza
New England Journal of Medicine
2011
Corpus ID: 65579
BACKGROUND Angiogenesis plays a role in the biology of ovarian cancer. We examined the effect of bevacizumab, the vascular…
Expand
Highly Cited
2010
Highly Cited
2010
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
R. Kurman
,
I. Shih
American Journal of Surgical Pathology
2010
Corpus ID: 33753425
Ovarian cancer is the most lethal gynecologic malignancy. Efforts at early detection and new therapeutic approaches to reduce…
Expand
Highly Cited
2010
Highly Cited
2010
Ovarian cancer development and metastasis.
E. Lengyel
American Journal of Pathology
2010
Corpus ID: 20398612
The biology of ovarian carcinoma differs from that of hematogenously metastasizing tumors because ovarian cancer cells primarily…
Expand
Highly Cited
2010
Highly Cited
2010
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
I. Vergote
,
C. Tropé
,
+15 authors
N. Reed
New England Journal of Medicine
2010
Corpus ID: 205091680
BACKGROUND Primary debulking surgery before initiation of chemotherapy has been the standard of care for patients with advanced…
Expand
Highly Cited
2005
Highly Cited
2005
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.
E. Sato
,
S. Olson
,
+15 authors
K. Odunsi
Proceedings of the National Academy of Sciences…
2005
Corpus ID: 21372718
In a recent report, [Zhang et al. (2003) N. Engl. J. Med. 348, 203-213], the presence of CD3+ tumor-infiltrating lymphocytes…
Expand
Highly Cited
2004
Highly Cited
2004
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
T. Curiel
,
G. Coukos
,
+18 authors
W. Zou
Nature Network Boston
2004
Corpus ID: 6864567
Regulatory T (Treg) cells mediate homeostatic peripheral tolerance by suppressing autoreactive T cells. Failure of host antitumor…
Expand
Highly Cited
2003
Highly Cited
2003
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.
Lin Zhang
,
J. Conejo-Garcia
,
+9 authors
G. Coukos
New England Journal of Medicine
2003
Corpus ID: 23584858
BACKGROUND Although tumor-infiltrating T cells have been documented in ovarian carcinoma, a clear association with clinical…
Expand
Highly Cited
2003
Highly Cited
2003
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A. Antoniou
,
P. Pharoah
,
+30 authors
D. Easton
American Journal of Human Genetics
2003
Corpus ID: 34521425
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is…
Expand
Highly Cited
1983
Highly Cited
1983
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
R. Bast
,
T. Klug
,
+9 authors
R. Knapp
New England Journal of Medicine
1983
Corpus ID: 25803092
The murine monoclonal antibody OC 125 reacts with an antigen (CA 125) common to most nonmucinous epithelial ovarian carcinomas…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE